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CASE REPORT Open Access
Case report: a diagnostically challenging
conjunctival mass caused by the Epstein-Barr
virus
Jordan V. Chervenkoff1*, Saul N. Rajak1, Paul G. Brittain1, David A. Wright2 and Victoria J M Barrett1
Abstract
We present a paediatric case of infectious mononucleosis in a 13-year old, manifesting with follicular conjunctivitis
and a conjunctival mass in one eye with no evidence of leucocytosis on the blood count. The diagnosis was confirmed
following surgical excision and biopsy. The case represented a diagnostic challenge due to its atypism and given the
steady increase in the prevalence of EBV-related ocular diseases in the last years, this report can serve as an example to
prompt earlier serological tests to identify the aetiology in similar cases. This is important because EBV can be treated
with acyclovir early in the active viral phase.
Introduction
The Epstein-Barr virus (EBV) is a double-stranded DNA
human herpes virus type 4 (HHV-4) [1]. It is transmitted
mainly through oral secretions and establishes latency by
invading memory B-cells, resulting in a high prevalence
throughout the world (about 90 % of adults are lifelong car-
riers) [2, 3]. Primary EBV infection generally occurs asymp-
tomatically in the early years of life but in adolescence its
hallmark is infectious mononucleosis (IM) [4, 5]. Viral pro-
liferation induces both cellular and humoral immunologic
responses and there is an increase in the overall number of
mononuclear lymphoid cells. Thus, the condition usually
presents with malaise, sweats, lymphadenopathy, fever and
pharyngitis [6]. Blood results often demonstrate marked
leucocytosis with a high differential lymphocyte cell count
and atypical enlarged lymphoid cells.
In ophthalmology, EBV has been implicated as a causa-
tive agent in various ocular malignancies and infections
which affect mostly the anterior segment (as a whole EBV-
related ocular diseases have been on the rise in the past
decade) [7–9]. The virus has a preference for mucosa-
associated lymphoid tissues (MALT), which are rich in B
lymphocytes, such as the conjunctiva or the lacrimal
glands [9–11].
In this article we present a case of an EBV-related fol-
licular conjunctivitis with an unusual unilateral bulbar and
subtarsal mass in a paediatric patient, which was diagnos-
tically challenging due to the atypical blood picture.
Case report
A 13-year old boy presented to the accident and emer-
gency with a large painless conjunctival mass under the
right upper eyelid. It had been first noticed two weeks
previously in the right supranasal quadrant and had
gradually increased in size since then. No itching or exces-
sive lacrimation were reported. The child had had a febrile
illness and had been complaining of malaise, intermittent
chills and sore-throat in the past 4 days. Otherwise, no
significant past medical or ophthalmic history was re-
ported and he was not on any medication. In addition,
there were no known allergies.
On examination, there was no pain during extraocular
movements (EOM), no proptosis or diplopia. Vision was
normal (Snellen acuity of 6/9) in both eyes. The intraocu-
lar pressure (IOP) was 18 mmHg bilaterally. Conjunctival
follicles were present on the upper and lower eyelids in
both eyes. The mass was obvious on lid retraction involv-
ing both the bulbar and subtarsal conjunctiva. It was
salmon-pink, non-tender and spread across the entire
conjunctiva superior to the limbus with no corneal in-
volvement, as seen on Fig. 1a. It had well delineated bor-
ders. Pupils were equal and reactive to light. The anterior
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chamber was deep and clear and no abnormalities were
detected in the posterior segment.
The boy’s temperature was 37.9 °C. One lymph node
was palpable on the left and two on the right–all in the
upper cervical chain. They were mobile and non-tender.
There was no organomegaly on palpation.
Blood tests indicated that serum alanine transaminase
(ALT) was elevated at 60 IU/L (normal range: 0–41 IU/L)
and haemoglobin was slightly low at 131 g/L (normal
range: 135–180 g/L). The overall and differential white
blood cell counts (WBC) were normal, as illustrated
on Table 1.
A successful excision was performed under general
anaesthetic and the mass was sent for a biopsy. Post-
operative results at 7 days were excellent (Fig. 1a and b).
The general symptoms had subsided and the child had
regained his normal function. There was a small residual
lymph node palpable on the left in the upper cervical
chain.
Discussion
Diagnosing the lesion was challenging and initially two
types of malignancies were considered: rhabdomyosar-
coma and lymphoma. Conjunctival MALT lymphoma is
the commonest malignant orbital tumour and it is char-
acteristically described as a “salmon-patch” on the
conjunctiva often arising from the fornix [12]. How-
ever, it characteristically presents later in life than the
age of the patient (median 65 years) [13]. On the other
hand, rhabdomyosarcoma is a common primary orbital
malignancy that can present with conjunctival swelling
starting in the superonasal segment [14]. The majority
of cases are observed in the first 10 years of life and
progress rapidly giving rise to visual disturbances due
to proptosis or limited EOM [14, 15]. Other differen-
tials to consider include malignant processes such as
ocular infiltration secondary to multiple myeloma or
infective causes such as nodular anterior scleritis,
chlamydia, herpetic infection, papilloma, tuberculosis
and migratory phlyctenulosis [16].
The histological report of the excised mass demon-
strated a population of large atypical centroblastic CD20
positive cells. These large proliferating B cells are repre-
sentative of EBV in the active latent stage [17]. A T-cell
mediated response against the rapidly dividing B cells
usually occurs in non-immunocompromised individuals
[18]. Hence, the conjunctival enlargement was the result
of the accumulation of histiocytes, pleomorphic lymph-
oid and plasma cells. Additionally, thirty to forty percent
of both B and T cell nuclei expressed Epstein-Barr
encoded RNAs (EBERs). Multiple polyclonal cell popula-
tions were detected by polymerase chain reaction (PCR)
looking for TCR or IGH gene rearrangements. This was
in keeping with a reactive, rather than a neoplastic
process [19].
Serology revealed the presence of Epstein-Barr nuclear
antigen (EBNA) immunoglobulin G (IgG) and EBV cap-
sid antigen immunoglobulin M (IgM) antibodies. Viral
EB DNA was detected at low levels at less than 1000
copies/ml. This serological profile was consistent with
the histological findings of a recent acute immunoreac-
tive process against EBV. Notably, the presence of EBNA
IgG was indicative of the virus establishing latency fol-
lowing primary infection (the serological genome detec-
tion assay was performed 42 days after the initial
presentation) [5].
The case we presented was challenging because lym-
phocytosis (a characteristic feature of IM) was not evi-
dent on the full blood count at initial presentation which
was about two weeks after the onset of symptoms.
Normally a relative or absolute increase in the number of
Fig. 1 Pre-operative extend of lesion (a) and post-operative outcomes (b)
Table 1 Total leucocyte and differential cell counts
WBC: 5.9 × 109/L (normal range: 4.0–11.0)
Differential:
Neutrophils 2.0 × 109/L (normal range: 2.0–7.5) 34.1 %
Lymphocytes 3.2 × 109 (normal range: 1.3–3.5) 54.5 %
Monocytes 0.6 × 109 (normal range: 0.2–0.8) 9.9 %
Eosinophils 0.0 × 109 (normal range: 0.0–0.4) 0.5 %
Basophils 0.1 × 109 (normal range: 0.0–0.1) 1 %
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lymphocytes (with a 15–25 % increase in atypical cells)
would be expected within the first 14 days [20]. Due to
the cross-reactivity of some of the antibodies, the Mono-
spot test can be used to confirm the diagnosis [20]. Its
specificity is close to 100 % (96–100 %), however because
about 10 % of people do not produce heterophil anti-
bodies it is less sensitive (70–92 %) [21]. A clinical picture
highly suggestive of IM in addition to a positive Monospot
test can be used to exclude other causes of infectious
mononucleosis such as: cytomegalovirus (CMV), herpes
symplex, Toxoplasma gondii and human immunodefi-
ciency virus type I (HIV-1).
Retrospectively, the elevated ALT presented a clue due
to the characteristic elevation of liver transaminases in IM
[22]. As a difference, alkaline phosphatase and gamma-
glutamyl transpeptidase levels do not usually change in IM.
Young patients with suspicious lymphoid periocular
lesions with a recent history of a febrile illness, malaise,
lymphadenopathy, pharyngitis and other presenting fea-
tures of IM should be offered a full blood count and
serological studies to check for recent EBV infection or
reactivation. If the aetiology is viral and depending on
the extent of the mass, surgical management can be of-
fered, as in our case. Otherwise, acyclovir can be used
because the EB virus is susceptible to it in the active
phase. Moreover, there have been reports where spon-
taneous regression of a smaller nodule of similar origin
was observed, which demonstrated that conservative
treatment may also be an option [23].
Summary points
We presented a case of an EBV-related conjunctival
mass in a paediatric patient with a recent primary in-
fection and symptoms of infectious mononucleosis. The
blood picture was not fully characteristic and the instance
emphasised the importance of recognising the early signs
of IM and treating accordingly. Ultimately, surgical exci-
sion was performed and the child had a successful recov-
ery shortly after.
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